• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

作者信息

Müller F M, Weig M, Peter J, Walsh T J

出版信息

J Antimicrob Chemother. 2000 Aug;46(2):338-40. doi: 10.1093/jac/46.2.338.

DOI:10.1093/jac/46.2.338
PMID:10933673
Abstract
摘要

相似文献

1
Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.来自患有口咽念珠菌病的HIV感染儿童的临床白色念珠菌分离株中唑类药物对酮康唑、氟康唑、伊曲康唑和伏立康唑的交叉耐药性。
J Antimicrob Chemother. 2000 Aug;46(2):338-40. doi: 10.1093/jac/46.2.338.
2
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.接受长期氟康唑治疗口腔念珠菌病的HIV感染患者中念珠菌属唑类耐药性的出现。
J Antimicrob Chemother. 1995 Jan;35(1):103-14. doi: 10.1093/jac/35.1.103.
3
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.来自患有口腔念珠菌病的HIV阳性患者的念珠菌分离株中具有临床意义的唑类交叉耐药性。
AIDS. 1997 Dec;11(15):1839-44. doi: 10.1097/00002030-199715000-00008.
4
Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.与一名HIV感染患者的白色念珠菌亚菌株相关的稳定唑类耐药性。
Oral Dis. 1997 May;3 Suppl 1:S102-9. doi: 10.1111/j.1601-0825.1997.tb00336.x.
5
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.复发性口咽念珠菌病合并人类免疫缺陷病毒感染患者中白色念珠菌氟康唑耐药菌株的出现。
J Clin Microbiol. 1994 Sep;32(9):2092-8. doi: 10.1128/jcm.32.9.2092-2098.1994.
6
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.患有口咽念珠菌病的伊朗艾滋病毒/艾滋病患者：念珠菌属的鉴定、患病率及抗真菌药敏性
Lett Appl Microbiol. 2018 Oct;67(4):392-399. doi: 10.1111/lam.13052. Epub 2018 Aug 16.
7
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).在瓦加杜古（布基纳法索）对 8 种抗真菌药物的白色念珠菌临床分离株的体外敏感性。
J Mycol Med. 2017 Dec;27(4):469-475. doi: 10.1016/j.mycmed.2017.07.001. Epub 2017 Jul 25.
8
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.他克莫司与唑类抗真菌药对唑类耐药白色念珠菌菌株的协同作用。
J Antimicrob Chemother. 1998 Dec;42(6):747-53. doi: 10.1093/jac/42.6.747.
9
Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.伊朗 HIV 感染并发口腔念珠菌病患者的念珠菌临床分离株对氟康唑耐药的机制。
J Mycol Med. 2016 Mar;26(1):35-41. doi: 10.1016/j.mycmed.2015.10.007. Epub 2015 Nov 25.
10
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.来自接受酮康唑治疗的艾滋病患者的口腔念珠菌分离株中的唑类耐药性。
Diagn Microbiol Infect Dis. 1998 Nov;32(3):211-6. doi: 10.1016/s0732-8893(98)00107-2.

引用本文的文献

1
A nanocarrier system that potentiates the effect of miconazole within different interkingdom biofilms.一种增强咪康唑在不同跨界生物膜中作用效果的纳米载体系统。
J Oral Microbiol. 2020 Jun 7;12(1):1771071. doi: 10.1080/20002297.2020.1771071.
2
Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis.埃塞俄比亚 HIV 感染合并口咽念珠菌病患者酵母菌分离株的菌种谱及体外抗真菌药敏模式
Int J Microbiol. 2016;2016:3037817. doi: 10.1155/2016/3037817. Epub 2016 Jan 5.
3
Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia.
在埃塞俄比亚西北部，晚期艾滋病患者中频繁检测到“唑类”耐药念珠菌属。
BMC Infect Dis. 2013 Feb 12;13:82. doi: 10.1186/1471-2334-13-82.
4
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial.体外活性研究：棘白菌素类药物与其他药物对 3 期临床试验中食管念珠菌病相关分离株的作用。
J Clin Microbiol. 2010 Jul;48(7):2613-4. doi: 10.1128/JCM.00806-10. Epub 2010 May 26.
5
In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.瑞替加酸B单独及与唑类抗真菌药联合对白色念珠菌的体外活性
Antimicrob Agents Chemother. 2009 Apr;53(4):1586-91. doi: 10.1128/AAC.00940-08. Epub 2009 Jan 26.
6
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis.坦桑尼亚原发性和复发性口咽念珠菌病HIV感染患者口腔酵母菌分离株的物种分布及体外抗真菌药敏性
BMC Microbiol. 2008 Aug 12;8:135. doi: 10.1186/1471-2180-8-135.
7
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.来自人类免疫缺陷病毒患者口咽部位以及巴伐利亚州环境中的酿酒葡萄的酵母对医学和农业用唑类药物的交叉耐药性。
Antimicrob Agents Chemother. 2007 Aug;51(8):3014-6. doi: 10.1128/AAC.00459-07. Epub 2007 Jun 4.
8
Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome.儿科重症监护患者侵袭性念珠菌病：流行病学、危险因素、管理及结局
Intensive Care Med. 2007 Jul;33(7):1272-1283. doi: 10.1007/s00134-007-0672-5. Epub 2007 May 15.
9
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.伏立康唑联合米卡芬净对念珠菌、曲霉菌、赛多孢属菌及茄病镰刀菌的作用。
Antimicrob Agents Chemother. 2005 Dec;49(12):5157-9. doi: 10.1128/AAC.49.12.5157-5159.2005.
10
Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.与CdCDR1和CdCDR2表达增加相关的3型都柏林念珠菌分离株中唑类药物敏感性降低。
Antimicrob Agents Chemother. 2005 Apr;49(4):1312-8. doi: 10.1128/AAC.49.4.1312-1318.2005.